ERK, AP-1 and Nrf2 and block HO-1 protein expression. The present study, furthermore, demonstrated arsenicinduced expression of arsenic response protein 2 (ARS2) that was regulated by p38 MAPK, ERK and NF-κB. To our knowledge, this is the first report showing that ARS2 involved in arsenic-induced nephrotoxicity, while TMP pretreatment prevented such an up-regulation of ARS2 in HK-2 cells. Given ARS2 and HO-1 sharing the similar regulation mechanism, we speculated that ARS2 might also mediate cell survival in this procession. In summary, our study highlighted a role of HO-1 in the protection against arsenic-induced cytotoxicity downstream from the primary targets of TMP and further indicated that TMP may be used as a potential therapeutic agent in the treatment of arsenicinduced nephrotoxicity.
Introduction
Arsenic (As) is an important environmental contaminant affecting more than 140 million people worldwide through contaminated drinking water (Rodriguez-Lado et al. 2013) . Recent epidemiologic studies in a rural US population, in some regions of China and especially in Bangladesh suggest arsenic is a major risk factor for kidney disease (Chen et al. 2011; Zheng et al. 2013) . Kidney is one of the targeted organs of arsenic cytotoxicity that could cause renal dysfunction, proteinuria and chronic kidney disease (CKD) (Yu et al. 2013; Michael 2013; Ruiz-Hernandez et al. 2015; Zheng et al. 2014; Chen et al. 2014) . Our recent study demonstrated that sodium arsenite at a clinically relevant dose induced cytotoxicity in human renal proximal tubular epithelial cell line, HK-2, which served as a representative cell model for exposures of the human kidney to As, drug-induced nephrotoxicity and acute kidney injury (Huang et al. 2015; Peraza et al. 2003 Peraza et al. , 2006 Wang et al. 2013b) . Furthermore, our recent results indicated that such a nephrotoxicity was associated with a dramatic increase in intracellular ROS production, mitochondrial dysfunction, inflammation, apoptosis and autophagy (Gong et al. 2014) . However, the precise molecular mechanisms responsible for arsenic nephrotoxicity remain largely unclear.
The inducible heme oxygenase-1 (HO-1) could exhibit anti-apoptotic, anti-oxidative and anti-inflammatory properties and thus be a renal protectant in multiple kidney injuries, such as acute kidney injury (AKI) induced by ischemia or nephrotoxicity induced by cisplatin and contrasting solutions (Chang et al. 2014; Miyagi et al. 2014) . The critical role of HO-1 has also been reported in several organ injuries (Wang and Dore 2007; Billings et al. 2014) . Given that HO-1 also has been identified as a response biomarker for arsenic exposure in various types of cells, we were very interested: (1) What is the role of HO-1 in As-induced nephrotoxicity (Gong et al. 2014 ) at clinically relevant doses? (2) What are the intricate molecular mechanisms involving in the regulation of HO-1 induction during As nephrotoxicity?
Furthermore, we have previously identified 2,3,5,6-tetramethylpyrazine (TMP), a compound extracted from the Chinese medicinal plant Ligusticum wallichi (Chuanxiong) as a protective agent against arsenic nephrotoxicity, which could attenuate ROS production, inflammation and cell death (Gong et al. 2014) . One of the main aims of the current study was to further elucidate a potential relationship between HO-1 production and the renal protection by antioxidant TMP in arsenic nephrotoxicity, which is not well understood.
Arsenic response protein 2 (ARS2, also known as Srrt) was first isolated as a gene product conferring resistance to arsenite and arsenate in Ass/S5 cell line (Rossman and Wang 1999) . Based on the very limited published data, ARS2 has been shown to be essential for the development of plants and mammals and also acts as a transcriptional regulator of Sox2 in neural stem cell (Kiriyama et al. 2009; Wilson et al. 2008; Andreu-Agullo et al. 2012) . However, the precise biological functions of ARS2 in mammalian are largely unknown (Wilson et al. 2008; Andreu-Agullo et al. 2012) . The previous work from our laboratory has shown an up-regulation of ARS2 expression in human neural stem cell after arsenic exposure (Ivanov and Hei 2013) , which suggested that ARS2 might be involved in arsenic-induced cytotoxicity and supported the previous suggestion that ARS2 has essential functions (Wilson et al. 2008) . However, the signaling mechanism regulating ARS2 induction is still unclear, and a role of ARS2 in arsenic nephrotoxicity has not been reported so far.
In the present study, we have further investigated the potential relationships between HO-1 induction, TMPmediated renal protection and ARS2 expression in the suppression of arsenic nephrotoxicity.
Materials
All chemicals were purchased from Sigma (St. Louis, MO, USA) unless otherwise stated. NF-κB inhibitor Bay 11-7082 (Bay), MAPK p38 inhibitor SB203580 (SB) and ERK inhibitor U0126 (U0) were obtained from Calbiochem (La Jolla, CA, USA), and JNK inhibitor SP600125 (SP) was obtained from Biomol (Plymouth Meeting, PA, USA).
Cell culture and treatment
The human proximal tubular cell line HK-2 (American Type Culture Collection, Manassas, VA, USA) was grown in culture medium (keratinocyte serum-free medium + 5 ng/ml epidermal growth factor and 50 μg/ ml bovine extract + 100 U/ml penicillin and 100 μg/ ml of streptomycin) at 37 °C and 5 % CO 2 humidified environment.
The next stock solutions were prepared: 50 mM sodium arsenite, antioxidant N-acetylcysteine (NAC, 10 mM), TMP (50 μM, 100 μM) in PBS, NF-κB inhibitor Bay (5 μM), MAPK p38 inhibitor SB (10 μM), ERK inhibitor U0 (10 μM) and JNK inhibitor SP (10 μM) in DMSO, and HO-1 inhibitor zinc protoporphyrin (ZnPP, 2 μM) in methanol. NAC, TMP and other inhibitors were added into media 30 min before As.
Intracellular ROS detection
Dihydroethidium (DHE, Invitrogen, Eugene, OR) method to detect intracellular superoxide production was used. After 24-h As treatment, cells were exposed to 2 μM DHE 45 min at 37 °C in the dark and then washed twice with PBS. Finally, fluorescence-activated cell sorter (FACS) analysis was performed (Becton-Dickinson, Franklin Lakes, NJ) using the CellQuest program. Samples were analyzed in triplicate, and all experiments were repeated three times independently.
Analyses of apoptosis by PI staining and FACS assay and TUNEL staining
Apoptotic cells were identified by diminished DNA content in the sub-G1 population of normal diploid cells by FACS assay after staining with propidium iodide (PI) (Gong et al. 2010) . Approximately 20,000 counts were made for each sample. Finally, the data were collected and analyzed with CellQuest program combined with FACS machine. Apoptotic levels were calculated by evaluating the percentage of events accumulated in the sub-G1 position. Samples were analyzed in triplicate and repeated 3 times.
To further confirm apoptotic cell death, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) staining was performed using a ClickiT TUNEL Alexa Fluor 488 Imaging Assay (Invitrogen, Grand Island, NY) according to the manufacturer's instructions except that PI replaced Hoechst 33342 to mount cells and label all nuclei. Stained nuclei were analyzed by a Nikon confocal microscope (Nikon TE200-C1) at 24 °C room temperature. TUNEL-positive cell numbers from 20 different fields (a total of 2000-2500 cells) were counted to get an average number of cells per field.
Mitochondrial network morphology assay
Mitochondrial network morphology and activity were visualized by using MitoTracker Green (Molecular Probes, Invitrogen). In brief, cells were grown on 6-well plate and incubated with 200 nM MitoTracker Green for another 20 min at 37 °C after 6-h As treatment. After three-time washes with PBS, cells were fixed with 4 % paraformaldehyde. Confocal fluorescence microscopy images were captured, and mitochondrial network morphology (tubular and non-tubular) was quantified by Image J software (NIH). Each treatment was randomly selected 20 noncontiguous fields for further observation and analysis, generally, each field containing 20-25 cells with mitochondrial networks. Percentages of normal (tubular) and abnormal (non-tubular) mitochondrial network morphologies were counted.
Mitochondrial function assay: cytochrome c oxidase (Cox) and succinate dehydrogenase (SDH) histochemistry
Cox and SDH histochemistry were monitored as described previously (Gong et al. 2014) . In brief, cells were cultured on glass cover inside a 6-well plate. After 6 h indicated treatment, cells on glass cover were allowed to dry at room temperature for 1 h and then followed by 15-min preincubation at room temperature with 1 mM CoCl 2 and 50 μl DMSO in 50 mM Tris-HCl, pH 7.6, containing 10 % sucrose. All samples were rinsed once in PBS and incubated for another 3 h with incubation medium (10 mg cytochrome c, 10 mg of DAB hydrochloride, 2 mg of catalase and 25 μl DMSO resolved in 10 ml 0.1 M phosphate buffer, pH 7.6). After further three-time rinse, all samples were mounted on warm glycerin gelatin and observed under Nikon LABOPHOT-2 microscope to capture images with SPOT Basic ™ software. Quantification of histochemical staining was performed with Image J software (NIH). Camera light settings were standardized, and color images were captured with 40× objective.
Western blotting
After the various treatments, whole cell lysates were prepared by incubation in RIPA buffer (Invitrogen). For nuclear transcription factor Nrf2 immunoblotting analysis, nuclear extracts were prepared using methods described previously (Schreiber et al. 1989) . Protein concentrations were determined with Bio-Rad DC protein assay (Bio-Rad Laboratories, Calif., USA) using bovine serum albumin as the standard. The resulting protein samples underwent SDS-PAGE gel electrophoresis and were transferred to PVDF membrane.
The specific primary antibodies included the following rabbit Abs: anti-HO-1 (Enzo Life Sciences), anti-Bcl-xl (Cell Signaling), anti-Bax (Cell Signaling), anti-PARP (Cell Signaling), anti-pro-caspase-9 (Cell Signaling), anti-Nrf2 (Cell Signaling), anti-JNK (Cell Signaling), anti-phospho-JNK (Cell Signaling), anti-ERK (Cell Signaling), anti-phospho-ERK (Cell Signaling), anti-p38 MAPK (Cell Signaling), anti-phospho-p38 MAPK (Cell Signaling), anti-ARS2 (Santa Cruz), antihistone H3 (Cell signaling) and mouse anti-beta actin (Sigma).
Statistical analysis
The data were presented as mean ± SD for a minimum of three independent experiments. All comparisons were made using either one-way ANOVA or a two-tailed t test analysis depending on how many conditions were compared in each experiment. One-way ANOVA was followed by Tukey's post hoc test. A value of p < 0.05 was considered significant.
Results

2,3,5,6-Tetramethylpyrazine (TMP) inhibited arsenic-induced ROS-dependent HO-1 expression
Arsenic (As) has been identified as inducer of heme oxygenase-1 (HO-1) expression in many cells and tissues (Teng et al. 2013; Li et al. 2013) . Consistent with these reports, we demonstrated that the induction of HO-1 protein expression was dose and time dependent in HK-2 cells after As exposure. Since the As dose range of 2.0-10 μM is successfully applied for treating acute promyelocytic leukemia (APL) and multiple myelomas Hei 2004, 2005; Shen et al. 1997) , we therefore choose this dose range for our present study. Furthermore, antioxidants N-acetylcysteine (NAC) and TMP significantly inhibited arsenic-induced HO-1 expression (Fig. 1a, b ). In contrast, Fig. 1 TMP inhibited arsenic-induced ROS-dependent HO-1 expression in HK-2 cells. a, b HK-2 cells were exposed to sodium arsenite at indicated doses for 3, 6 and 24 h alone or in a combination with either 10 mM NAC or 50-100 μM TMP. Arsenite (As) exposure induced HO-1 protein expression in a dose-and time-dependent manner, whereas NAC and TMP pretreatment sufficiently blocked HO-1 up-regulation. c, d Compared with 10 mM NAC, 10 μM AG, the inhibitor of iNOS, failed in preventing HO-1 up-regulation. β-actin was used as loading control. Quantitative densitometry of protein bands was performed. Values are mean ± SD (n = 3), (**) p < 0.01 versus control aminoguanidine (AG), the iNOS inhibitor, failed in preventing HO-1 up-regulation (Fig. 1c, d ).
Blocking HO-1 with ZnPP augmented As-induced apoptosis and ROS production
To verify the role of HO-1 in arsenic (As) nephrotoxicity, zinc protoporphyrin (ZnPP), a known inhibitor of HO-1 enzymatic activity, was used. Interestingly, ZnPP aggravated sodium arsenite (10 μM)-induced cytotoxicity and apoptosis that was confirmed by increased percentage of cells accumulated in the sub-G1 position (35.7 vs. 12.5 %) determined by FACS analysis of PI-stained cell nuclei (Fig. 2a, b) and by % TUNEL-positive staining cells (Fig. 2c, d) .
Several studies have shown that the induction of HO-1 by As is ROS dependent (Fan et al. 2010; Teng et al. 2013) . Our previous data have demonstrated that As exposure elevated ROS production in HK-2 cells (Gong et al. 2014) . The present results demonstrate that ROS production is upregulated by 2.19-fold with 10 μM sodium arsenite treatment. Furthermore, combined treatments with ZnPP and 10 μM sodium arsenite resulted in a 5.35-fold increase in ROS production highlighting antioxidant role of HO-1 activation (Fig. 2e, f) . Fig. 2 Blocking HO-1 activity with ZnPP augmented arsenicinduced apoptosis and ROS production. Apoptosis levels and intracellular ROS production were measured 24 h after arsenic (As) treatment with or without 2 μM ZnPP pretreatment of HK-2 cells. a, b Levels of apoptosis were calculated by evaluating the percentage of cells accumulated in the sub-G1 position after PI staining DNA. c, d Apoptosis was determined by TUNEL staining, and average percentages of TUNEL-positive cells were assessed in each group. e, f 100 μM TMP and 10 mM NAC inhibited As-induced ROS generation at 24 h, while 2 μM ZnPP augmented ROS generation. Values are mean ± SD (n = 3), (*) p < 0.05 versus Con; (**) p < 0.01 versus Con; ( ## ) p < 0.01 versus 10 μM As
Inhibition of HO-1 activity with ZnPP augmented As-induced mitochondrial dysfunction
To further investigate the relationships among mitochondrial alterations, As nephrotoxicity, and blocking HO-1 activity, mitochondrial morphology was analyzed at the single cell level in Mito Tracker Green-stained HK2 cells. As shown in Fig. 3a , a large number of cells (84.6 %) presented a normal (tubular) shape of mitochondrial network in the control group, while a number of cells with the abnormal (elongated or fragmented) mitochondrial networks were obviously increased in 10 μM sodium arsenite-treated group; accordingly, the percentage of cells with tubular mitochondria in this group dropped to 35.7 %. Augmented mitochondrial morphology changes were observed in ZnPP pretreatment group, whereas TMP and NAC pretreatment can effectively prevent this change in mitochondrial network morphology, and percentages of normal tubular morphology were 33.5, 72.5 and 69.8 % (Fig. 3b) . Our previous study (Gong et al. 2014 ) indicated that sodium arsenite induced mitochondrial dysfunction in HK-2 cells, shown as strong loss of mitochondrial membrane potential and decreased Cox enzyme activity, which could be inhibited by NAC and TMP. In the present study, results of Cox enzyme histochemistry and mitochondrial membrane potential assay (data not shown) indicated that blocking HO-1 activity with ZnPP aggravated such a mitochondria dysfunction. Interestingly, the enzyme activity of SDH, or Complex II, encoded entirely by nuclear genome, was not significantly impaired by sodium arsenite treatment or ZnPP (Fig. 3c-e) . 
TMP prevented As-triggered the intrinsic apoptotic pathway activation in HK-2 cells
To explore whether sodium arsenite-induced apoptosis in HK-2 cells used the intrinsic mitochondrial pathway, the protein levels of Bax and Bcl-xl, a pro-apoptotic and an anti-apoptotic member, respectively, of the Bcl-2 family, were analyzed by Western blotting. Sodium arsenite treatment for 24 h resulted in a reduction of anti-apoptotic Bclxl protein expression and an increase in the pro-apoptotic Bax protein expression (Fig. 4a) . The decrease in pro-caspase-9 protein levels (that indicated on caspase-9 activation) and caspase-9/caspase-3-dependent PARP1 cleavage induced by sodium arsenite treatment further demonstrated the involvement of intrinsic apoptotic pathway (Fig. 4a) . Co-treatment with TMP (50 and 100 μM) prevented arsenic-triggered the intrinsic apoptotic pathway activation, and 100 μM TMP showed higher protective efficiency (Fig. 4a) .
TMP prevented As-induced HO-1 activation through inhibiting the activation of MAPKs/AP-1 pathways
Transcription factor AP-1 interacts with the corresponding binding site in the HO-1 gene promoter region and mediates HO-1 expression (Zhang et al. 2006) . Furthermore, members of the MAPK family (ERK, JNK and p38) contributed to activation of AP-1 (Mossman et al. 2006 ). Thus, we next monitored impact of As on the activation of MAPK family and AP-1 in HK-2 cells. As shown in Fig. 4b and Fig. 5a , b, As treatment induced MAPK activation (the ERK, JNK and p38 MAPK) 3 h after treatment in a dosedependent manner. However, individual members showed different dynamic changes. Phospho -JNK peaked at 3 h and showed the fastest down-regulation, phospho-ERK and phospho-p38 MAPK peaked at 6 h. Up-regulation of phospho-p38 MAPK was very durable and continued until 24 h. TMP co-treatment was very effective against Asinduced ERK and MAPK p38 activation, but demonstrated only modest effects against JNK activation (Figs. 4b, 5a,  b) . Meanwhile, as an important member of AP-1 family, nuclear phospho-c-Jun protein expression increased after As exposure in a dose-dependent manner, while both 50 and 100 μM TMP efficiently inhibited As-induced phospho-c-Jun up-regulation; 100 μM TMP demonstrated higher efficiency (Fig. 5c, d) .
To further confirm a role of MAPKs in As-induced HO-1 expression, small molecule inhibitors of JNK, ERK and p38 MAPK were used. As shown in Fig. 6a -c, SB203580 (10 μM), an inhibitor of MAPK p38, and SP600125 (10 μM), a JNK inhibitor, efficiently downregulated HO-1 protein expression induced by 3-h As exposure, while pretreatment with ERK inhibitor U0126 (10 μM) did not affect As-induced HO-1 expression, demonstrating the critical roles for MAPK p38 and JNK in Fig. 4 TMP prevented arsenic-triggered activations of the intrinsic apoptotic pathway and ERK pathway in HK-2 cells. a As treatment (24 h) increased protein levels of pro-apoptotic Bax and pro-caspase-9 expressions and decreased levels of anti-apoptotic Bcl-xl, and PARP cleavage, while TMP (50 and 100 μM) pretreatment prevented As-triggered the intrinsic apoptotic pathway activation. b As-induced ERK activation was verified by increased level of phospho-Thr202/ Tyr204 ERK (p-ERK) expression, which was inhibited by TMP pretreatment. β-actin was used as loading control. Values are mean ± SD (n = 3) As-induced induction of HO-1 protein expression. Meanwhile, both 50 and 100 μM TMP effectively inhibited As-induced MAPK activation, and compared with 50, and 100 μM TMP showed more efficient in inhibiting MAPK activation (Figs. 4b, 5a, b) .
TMP prevented As-induced HO-1 through inhibiting the activation of Nrf2 and NF-κB pathways
Two additional transcription factors, Nrf2 and NF-κB, control HO-1 gene and protein expression (Garnier et al. 2013; Wang et al. 2012; Lim et al. 2014) . We monitored Nrf2 and phospho-NF-κB p65 (active form) nuclear protein levels after As exposure of HK-2 cells. As shown in Fig. 6e , the nuclear Nrf2 protein was up-regulated in a dose-dependent manner as early as 3 h after As exposure and peaked at 6 h, while the increased expression lasted to 24 h. A similar dynamics was previously observed for nuclear phospho-NF-κB expression (Gong et al. 2014) . To gain further insight into the relationship between activation of NF-κB p65 and HO-1 up-regulation induced by As exposure, we used co-treatment with Bay11-7082, an inhibitor of NF-κB, which selectively and irreversibly inhibits the inducible phosphorylation of IκB-α. As shown in Fig. 6d , As-induced HO-1 protein expression was strongly downregulated by 5 μM Bay11-7082. On the other hand, cotreatment with TMP partially suppressed As-induced Nrf2 up-regulation (Fig. 6e) . The similar effects of TMP on NF-κB activation were previously observed (Gong et al. 2014) .
TMP prevented As-induced up-regulation of ARS2 expression in HK-2 cells
To elucidate a role of transcription factor ARS2 in arsenicinduced kidney injury, we determined As-induced protein MAPK (p-p38) expression, respectively, which were inhibited by TMP pretreatment. c and d 6-h As exposure resulted in nuclear phospho-c-Jun up-regulation, while both 50 and 100 μM TMP efficiently inhibited As-induced nuclear c-Jun activation. Histone H3 (Histon) and β-actin were used as loading controls for nuclear and total proteins, respectively. Values are mean ± SD (n = 3); (*) p < 0.05 versus Con; (**) p < 0.01 versus Con; ( # ) p < 0.05 versus 2.5 μM As, ( ## ) p < 0.01 versus 10 μM As expression of ARS2 in HK-2 cells. As shown in Fig. 7a , As treatment increased ARS2 protein expression, and such an up-regulation was peaking at 6 h and then gradually decreased. TMP (100 μM) efficiently inhibited As-induced ARS2 up-regulation. Next, to achieve the purpose whether MAPKs and NF-κB contributed to As-mediated ARS2 induction, we used co-treatment with As and specific molecule inhibitors. SB203580 (an inhibitor of p38) and U0126 (an inhibitor of ERK), but not SP600125 (an inhibitor of JNK), obviously inhibited As-induced ARS2 up-regulation at 6 h, which indicated MAPK p38 and ERK acted at the upstream of ARS2 expression (Fig. 7c-e) . Additionally, as Fig. 7b demonstrates, Bay11-7082 reversed the effect of As on ARS2, which indicated that As-induced ARS2 up-regulation was also modulated by NF-κB activation in HK-2 cells.
Discussion
Our previous study (Gong et al. 2014) identified that sodium arsenite at a clinically relevant dose also might be a risk factor for kidney, while TMP could prevent such an As-induced nephrotoxicity by reducing ROS production, preventing mitochondria dysfunction and suppressing activation of pro-inflammatory signals, including β-catenin, NF-κB, TNF-α and cyclooxygenase-2 (COX2). However, the precise renal cellular adaptive mechanism and antioxidant-mediated protective responses against arsenic exposure with clinically relevant dose are still not clear. In the present study, we revealed that clinically relevant concentrations of sodium arsenite induced dose-dependent and specific activation of MAPKs that further activated inhibited arsenic-induced up-regulation of nuclear Nrf2 in HK-2 cells (e). Histone H3 (Histon) and β-actin were used as loading controls for nuclear and total proteins, respectively. Values are mean ± SD (n = 3), (*) p < 0.05 versus Con; (**) p < 0.01 versus Con; ( ## ) p < 0.01 versus 10 μM As transcription factors Nrf2, NF-κB and AP-1/c-Jun, which then control the downstream antioxidant response of HO-1 in HK-2 cells. Additionally, we observed the up-regulation of transcription factor ARS2 expression in this processes, which strongly supported the previous speculation about essential function of ARS2 (Wilson et al. 2008) . Interestingly, TMP inhibited As-induced Nrf2, AP-1 and MAPK family activations, accordingly, and reduced HO-1 and ARS2 expressions, which might contribute to its nephroprotective effects.
HO-1 has been identified as a biological hallmark of cells in response to unfavorable environment, including oxidative stress (Teng et al. 2013; Lee et al. 2012 ). In our previous study (Gong et al. 2014) , As exposure dramatically increased cellular ROS production in HK-2 cells, and antioxidant NAC and TMP efficiently prevented Asinduced cytotoxicity and ROS production. In the present study, the involvement of oxidative stress in As-induced nephrotoxicity was further investigated by monitoring HO-1 expression. As shown in Fig. 1a, b , we identified the induced HO-1 protein expression after As exposure was in a dose-and time-dependent manner, whereas the treatment of TMP and antioxidant NAC blocked As-induced HO-1 expression. Such a result also suggested the tight relationship between HO-1 induction and intracellular ROS production after arsenite exposure in HK-2 cells. Interestingly, aminoguanidine (AG), the inhibitor of iNOS, has no effect on the expression of HO-1 in response to As, which suggested that As-induced HO-1 production might mainly be mediated by ROS, not nitrosative stress.
Furthermore, a role of HO-1 in As-induced nephrotoxicity was investigated using ZnPP, a known inhibitor of HO-1. Blocking As-induced HO-1 enzymatic activity by ZnPP resulted in decreased cell viability (data not shown) and promoted As-induced programmed cell death ascertained by increased sub-G1 phase and TUNEL-positive Fig. 7 Arsenic-triggered ARS2 expression was NF-κB, p38 MAPK and ERK dependent in HK-2 cells. Pretreatment of TMP (a), Bay11-7082 (Bay) (b), SB203580 (SB) (c) and UO126 (UO) (e), while not SP600125 (SP) (d), efficiently inhibited As-induced ARS2 expression. β-actin was used as loading control for total proteins. Values are mean ± SD (n = 3), (*) p < 0.05 versus Con cells. Accordingly, cellular ROS production achieved 5.35-fold increasing, significantly higher than after As treatment. Our previous data have confirmed that mitochondrial damage was involved in As-induced nephrotoxicity (Gong et al. 2014) . In the present study, we found that blocking HO-1 further exacerbated As-induced mitochondrial injury and respiratory chain damage, ascertained as a decrease in the number of tubular mitochondria and down-regulation in Cox expression. All these data mentioned above strongly demonstrated that HO-1 played a protective role in Asinduced nephrotoxicity, and blocking HO-1 augmented As-induced cell death, ROS production and mitochondrial injury. In the other studies, HO-1 also has been shown to protect kidney against several acute kidney injury (AKI) (Billings et al. 2014; Miyagi et al. 2014; Goodman et al. 2007) .
Nuclear factor erythroid derived-2 (Nrf2) is involved in one of the most important cellular defense mechanisms against oxidative stress by regulating cytoprotective enzymes expressions, for example, HO-1 (Zhang et al. 2012; Kilic et al. 2013) . Furthermore, Nrf2 has been viewed as a protective protein against genotoxic damage. Consistent with the above views, there is evidence that Nrf2 could protect human bladder urothelial cells ) from As toxicity and attenuate hyperglycemiainduced kidney injury in diabetic mice . In contrast, the present study demonstrated that Nrf2 and Nrf2-regulated cytoprotective HO-1 genes were activated after As exposure at a clinically relevant dose, and such an increased expression of Nrf2 and HO-1 failed to rescue HK-2 cells from As-induced cytotoxicity. Similar results were observed in As-treated oral squamous cells, which might suggest that Nrf2-and HO-1-dependent protection was overwhelmed by As cytotoxicity (Zhang et al. 2012) . Indeed, while up-regulation of HO-1 is regarded as cytoprotective under various experiment conditions, it can be non-sufficient to fully recover cells from oxidative damage, as shown in our study and other publication .
Although many studies highlighted the importance of Nrf2 pathway in As-induced HO-1 expression in different cell lines Pi et al. 2008) , indeed, the mechanisms underlying HO-1 induction are regulated by the complex signaling network. In the present study, we observed a discrepancy between Nrf2 and HO-1 protein expression after As exposure in HK-2 cells: As-induced HO-1 expression was in a dose-and time-dependent manner, whereas As-induced Nrf2 expression peaked at 6 h and then degraded gradually. Such discrepancy also suggested that As might induce HO-1 gene expression through Nrf2-independent pathways. The previous research suggested that Nrf2 played essential role for HO-1 induction only in the early and transient phase after As exposure in embryonic fibroblasts .
HO-1 induction is tightly regulated primarily at the transcriptional level, Nrf2 recruited BRG1 to the HO-1 enhancers and the promoter, meanwhile, activator protein-1 (AP-1) and NF-κB located in HO-1 gene promoter region (Zhang et al. 2006) . Our previous data identified that As with clinical dose induced phospho-NF-κB p65 nuclear protein (active form) expression in HK-2 cells (Gong et al. 2014) . In the present study, to gain insight into the functional relationship between NF-κB activation and HO-1 up-regulation in response to As, HK-2 cells were preincubated with Bay11-7082, a specific inhibitor of NF-κB, for 30 min followed by 10 μM sodium arsenite treatment for 6 h. Figure 6b shows co-treatment of 10 μM sodium arsenite and Bay substantially inhibited HO-1 expression as compared with As alone, which further indicated that the induction of HO-1 expression in As-induced nephrotoxicity is through multiple pathways and, at least partially, through NF-κB activation.
AP-1 is another transcription factor that could control the HO-1 gene expression (Zhang et al. 2006) . In addition, MAPKs contributed to AP-1 induction (Hsieh et al. 2014) . Thus, we next monitored As impact on the activations of MAPKs and AP-1 and investigated the relationship between MAPKs and HO-1 expression in HK-2 cells. As shown in Figs. 4b and 5, arsenic exposure resulted in MAPK family activations, which is very consistent to the other studies Kang et al. 2003 ), but such activation seemed to be cell and species dependent . For example, As exposure only strongly activated p38 MAPK in normal human lung fibroblast and did not activate ERK and JNK (Wang et al. 2013a) .
Additionally, the present study established that arsenic exposure within clinically relevant dose could activate AP-1 family member c-Jun in HK-2 cells (Fig. 5c, d ) that is very consistent to the previous study (Deshane et al. 2010) demonstrating its role for HO-1 induction in renal epithelial cell. Interestingly, only SB203580 (an inhibitor of p38) and SP600125 (an inhibitor of JNK), but not U0126 (an inhibitor of ERK), efficiently attenuated As-induced HO-1 production that confirmed only p38 MAPK and JNK, but not ERK, contributed to the up-regulation of HO-1 after As exposure in HK2 cells.
Taken together, our present data demonstrated that the regulation mechanisms of As-induced HO-1 expression were performed through multiple signal pathways, Nrf2, NF-κB, AP-1, p38 MAPK and JNK.
In our previous study, TMP could reverse the Asinduced sequence of pro-inflammatory signal regulators, including NF-κB, p38 MAPK, beta-catenin and COX2, and protect HK-2 cells against As-induced programmed cell death (autophagy and apoptosis) (Gong et al. 2014) . In current study, another novel finding is the demonstration that TMP could also suppress the activations of Nrf2, AP-1, JNK and ERK after As exposure, accordingly, block HO-1 protein expression in HK-2 cells. Furthermore, such protection was performed by preventing As-triggered activation of the intrinsic apoptotic pathway. Interestingly, TMP was also found to inhibit proliferation of human promyelocytic leukemia cell line HL-60 .
So far, there were no related reports, which focused on the effects of As on induction of transcription factor ARS2 in As-induced nephrotoxicity. In the present study, As treatment increased ARS2 protein expression. Interestingly, the dynamic change in As-induced ARS2 expression showed a similar manner with COX2 (Gong et al. 2014) . Similar to the effects on MAPKs, TMP efficiently inhibited ARS2 up-regulation. Nevertheless, attention should be paid to the very interesting phenomenon, demonstrating that Bay11-7082 (a specific inhibitor of NF-κB), SB203580 (an inhibitor of p38) and U0126 (an inhibitor of ERK), but not SP600125 (an inhibitor of JNK), attenuate the effects of As on ARS2 expression. This indicated that As-induced ARS2 up-regulation was modulated by the activations of NF-κB, p38 MAPK and ERK, but not JNK in HK-2 cells. To our knowledge, this is the first report demonstrating that ARS2 involved in As-induced nephrotoxicity and it was regulated by p38 MAPK, ERK and NF-κB. Further studies focusing on the potential function of ARS2 in As-induced nephrotoxicity is worthy of attention.
Although it is not clear which role ARS2 plays in Asinduced nephrotoxicity, but given ARS2 and HO-1 sharing the similar regulation mechanism, we thus hypothesize that ARS2 and HO-1 might mediate cell survival in response to As treatment in HK-2 cells. Previous report also has revealed that ARS2 played a role in RNA interference regulation during cell proliferation and in the ability of mammalian cells to proliferate (Gruber et al. 2009 ) that also gave the supporting evidence for our speculation of ARS2 mediating cell survival in As-induced nephrotoxicity in HK-2 cells.
In summary, the present study further confirmed that arsenic treatment at clinically relevant dose results in renal damage, additionally, the activations of Nrf2, AP-1, MAPK family and ARS2 involved in such a nephrotoxicity. Furthermore, the cytoprotective HO-1 induction after As exposure in HK-2 cells is mediated by multiple pathways, including Nrf2, NF-κB, AP-1, p38 MAPK and JNK. The current data also demonstrated TMP efficiently reverses As-induced Nrf2, NF-κB, AP-1, MAPK family activations and blocks the according HO-1 and ARS2 expressions. Although further studies are required, we can still propose TMP could be effective in the treatment of arsenic-induced nephrotoxicity.
